Aorta angiosarcoma
diseaseOn this page
Also known as angiosarcoma (disease) of aortaangiosarcoma of aortaangiosarcoma of the aortaaorta angiosarcoma (disease)aortic angiosarcomaaortic hemangiosarcomahemangiosarcoma of aortahemangiosarcoma of the aorta
Summary
Aorta angiosarcoma (MONDO:0003023) is a disease. A subtype of aortic malignant tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | aorta angiosarcoma |
| Mondo ID | MONDO:0003023 |
| DOID | DOID:4510 |
| NCIT | C5376 |
| UMLS | C1332312 |
| MedGen | 231071 |
| GARD | 0023331 |
| Anatomy (UBERON) | UBERON:0000947 |
| Is cancer (heuristic) | no |
Also known as: angiosarcoma (disease) of aorta · angiosarcoma of aorta · angiosarcoma of the aorta · aorta angiosarcoma (disease) · aortic angiosarcoma · aortic hemangiosarcoma · hemangiosarcoma of aorta · hemangiosarcoma of the aorta
Disease family
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › vascular disorder › arterial disorder › aortic disorder › aortic malignant tumor › aorta angiosarcoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.